Search research articles
Contact Us
Filters
Showing results (1-10 of 78) with videos related to
Page
of 8
Sort By:
Circulation
|
December 20, 2021
Fish Oil Supplements May Increase the Risk for Atrial Fibrillation: What Does This Mean?
Michelle Samuel, Stanley Nattel
Heart (British Cardiac Society)
|
March 12, 2024
Birth cohort effect in atrial fibrillation: a matter of detection?
Michelle Samuel, Michiel Rienstra
The Canadian Journal of Cardiology
|
July 19, 2023
Can We Define the Role of Cardiac Stress Testing After Percutaneous Coronary Intervention With the Use of Observational Data?
Guillaume Marquis-Gravel, Michelle Samuel
The Canadian Journal of Cardiology
|
September 11, 2019
Challenges in Assessing the Incidence of Atrial Fibrillation Hospitalizations
Michelle Samuel, James M Brophy
Circulation. Cardiovascular Quality and Outcomes
|
August 12, 2022
Real-Life Indications for Left Atrial Appendage Occlusion in Nonvalvular Atrial Fibrillation: Choosing Between Clinical Trials and Clinical Pragmatism
Guillaume Marquis-Gravel, Michelle Samuel
Future Cardiology
|
March 9, 2021
Lessons learned from large Cardiovascular Outcome Trials targeting inflammation in cardiovascular disease (CANTOS, CIRT, COLCOT and LoDoCo2)
Michelle Samuel, Jean-Claude Tardif
European Journal of Preventive Cardiology
|
July 1, 2022
Diabetes and atrial fibrillation: does the type of diabetes matter?
Michelle Samuel, James M Brophy
European Heart Journal
|
September 3, 2025
Inflammation reduction with colchicine in atherosclerotic cardiovascular disease
Michelle Samuel, Jean-Claude Tardif
The Canadian Journal of Cardiology
|
June 26, 2020
Will Colchicine Soon Be Part of Primary and Secondary Cardiovascular Prevention?
Michelle Samuel, David D Waters
Lancet (London, England)
|
March 9, 2023
Inflammation contributes to cardiovascular risk in patients receiving statin therapy
Jean-Claude Tardif, Michelle Samuel
Page
of 8
Search research articles
Search
Showing results (1-10 of 78) with videos related to
Sort By:
Page
of 8
Circulation
|
December 20, 2021
Fish Oil Supplements May Increase the Risk for Atrial Fibrillation: What Does This Mean?
Michelle Samuel, Stanley Nattel
Heart (British Cardiac Society)
|
March 12, 2024
Birth cohort effect in atrial fibrillation: a matter of detection?
Michelle Samuel, Michiel Rienstra
The Canadian Journal of Cardiology
|
July 19, 2023
Can We Define the Role of Cardiac Stress Testing After Percutaneous Coronary Intervention With the Use of Observational Data?
Guillaume Marquis-Gravel, Michelle Samuel
The Canadian Journal of Cardiology
|
September 11, 2019
Challenges in Assessing the Incidence of Atrial Fibrillation Hospitalizations
Michelle Samuel, James M Brophy
Circulation. Cardiovascular Quality and Outcomes
|
August 12, 2022
Real-Life Indications for Left Atrial Appendage Occlusion in Nonvalvular Atrial Fibrillation: Choosing Between Clinical Trials and Clinical Pragmatism
Guillaume Marquis-Gravel, Michelle Samuel
Future Cardiology
|
March 9, 2021
Lessons learned from large Cardiovascular Outcome Trials targeting inflammation in cardiovascular disease (CANTOS, CIRT, COLCOT and LoDoCo2)
Michelle Samuel, Jean-Claude Tardif
European Journal of Preventive Cardiology
|
July 1, 2022
Diabetes and atrial fibrillation: does the type of diabetes matter?
Michelle Samuel, James M Brophy
European Heart Journal
|
September 3, 2025
Inflammation reduction with colchicine in atherosclerotic cardiovascular disease
Michelle Samuel, Jean-Claude Tardif
The Canadian Journal of Cardiology
|
June 26, 2020
Will Colchicine Soon Be Part of Primary and Secondary Cardiovascular Prevention?
Michelle Samuel, David D Waters
Lancet (London, England)
|
March 9, 2023
Inflammation contributes to cardiovascular risk in patients receiving statin therapy
Jean-Claude Tardif, Michelle Samuel
Page
of 8